The prevalence of malaria infections among migrants from sub-Saharan Africa is considerably higher (8%), while Asian and Latin American migrants have a much lower prevalence, according to a study by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation. These findings can help inform screening strategies to combat malaria infections in migrant populations.

12677_lores

Source: CDC/ Neva Gleason

This blood smear photomicrograph revealed some of the ultrastructural morphology exhibited by a ring-form Plasmodium falciparum malarial parasite, which was found in a blood sample from a patient who had just begun therapeutic treatment with an unidentified agent.

Malaria is often thought of as a tropical disease, but a systematic review led by ISGlobal has shed light on a lesser-known aspect of this mosquito-borne disease: its prevalence among migrants in non-endemic areas.

Migrant populations currently make up 10% of the total population in EU countries and many of them come from malaria-endemic regions. However, as ISGlobal researcher Ana Requena notes, “screening of migrants arriving in European countries is not usually done, so we do not know the true percentage of those infected with the malaria parasite, especially since many of the infections can be asymptomatic.” 

Screening studies

To estimate the prevalence of malaria parasites in this population, Requena and her team searched several databases for studies conducted in Europe, USA, Canada, Australia or New Zealand where migrants had been systematically screened for malaria parasites. The researchers excluded studies in which people were tested because of malaria symptoms, as their aim was to capture asymptomatic infections.

Of the 1,819 studies initially identified, the review included 23 studies that met the criteria, with a total of 4,203 participants tested with PCR, 3,186 with microscopy, and 4,698 with rapid diagnostic tests (RDTs).

Regional variations

The prevalence of the malaria parasite varied widely between migrant groups. Sub-Saharan African migrants had the highest prevalence, with 8.3% testing positive by PCR, 4.3% by RDTs and 3.1% by microscopy.

Prevalence was highest among those from Central Africa (9.3% by PCR) and those who had arrived in their host country within the last year (11.6% by PCR).  In contrast, malaria parasite prevalence was much lower among Asian and Latin American migrants (0% and 0.4%, respectively, by PCR).

Not surprisingly, parasite prevalence based on PCR (which is much more sensitive) was two to three times higher than that detected by RDT or microscopy.

These findings can help inform screening strategies and guidelines for malaria control in migrant populations, the authors said.

“By identifying at-risk populations, health authorities can better tailor interventions to prevent and treat malaria in these communities, ultimately contributing to global efforts to eliminate this devastating disease,” says Requena.